High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$8.8M
$8,771,834
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
RYTM
S
RHYTHM PHARMACEUTICALS, INC.
German Christopher Paul
• Officer • Corporate Controller & CAO
Discretionary SellΔOwn -97.2%
2026-03-04
$502,790
|
||||||
| RYTM |
RHYTHM PHARMACEUTICALS, INC.
|
Officer • Corporate Controller & CAO
Discretionary SellΔOwn -97.2%
|
2026-03-04 | $502,790 | S | Form 4 |
| RYTM |
RHYTHM PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2026-02-19 | $444,004x4 | S | Form 4 |
| RYTM |
RHYTHM PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2026-02-17 | $361,810x5 | S | Form 4 |
| RYTM |
RHYTHM PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2026-02-12 | $156,380x4 | S | Form 4 |
| RYTM |
RHYTHM PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2026-02-11 | $272,766x3 | S | Form 4 |
| RYTM |
RHYTHM PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2026-02-10 | $279,429x3 | S | Form 4 |
| RYTM |
RHYTHM PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2026-02-05 | $358,599 | S | Form 4 |
| RYTM |
RHYTHM PHARMACEUTICALS, INC.
|
CFO
10b5-1 Sell
|
2026-02-04 | $344,145x3 | S | Form 4 |
|
RYTM
S
RHYTHM PHARMACEUTICALS, INC.
Cramer Pamela J.
• Officer • Chief Human Resources Officer
10b5-1 SellΔOwn -13.9%
2025-12-11
$371,850
|
||||||
| RYTM |
RHYTHM PHARMACEUTICALS, INC.
|
Officer • Chief Human Resources Officer
10b5-1 SellΔOwn -13.9%
|
2025-12-11 | $371,850 | S | Form 4 |
|
RYTM
S
RHYTHM PHARMACEUTICALS, INC.
Cramer Pamela J.
• Officer • Chief Human Resources Officer
10b5-1 SellΔOwn -13.9%
2025-11-20
$351,750
|
||||||
| RYTM |
RHYTHM PHARMACEUTICALS, INC.
|
Officer • Chief Human Resources Officer
10b5-1 SellΔOwn -13.9%
|
2025-11-20 | $351,750 | S | Form 4 |
|
RYTM
S
RHYTHM PHARMACEUTICALS, INC.
Cramer Pamela J.
• Officer • Chief Human Resources Officer
10b5-1 SellΔOwn -14.4%
2025-11-10
$351,500
|
||||||
| RYTM |
RHYTHM PHARMACEUTICALS, INC.
|
Officer • Chief Human Resources Officer
10b5-1 SellΔOwn -14.4%
|
2025-11-10 | $351,500 | S | Form 4 |
|
RYTM
S
RHYTHM PHARMACEUTICALS, INC.
Cramer Pamela J.
• Officer • Chief Human Resources Officer
10b5-1 SellΔOwn -48.2%
2025-11-07
$1,912,326Large
|
||||||
| RYTM |
RHYTHM PHARMACEUTICALS, INC.
|
Officer • Chief Human Resources Officer
10b5-1 SellΔOwn -48.2%
|
2025-11-07 | $1,912,326Large | S | Form 4 |
|
RYTM
S
RHYTHM PHARMACEUTICALS, INC.
Shulman Joseph
• Officer • Chief Technical Officer
10b5-1 SellΔOwn -53.4%
2025-10-30
$1,123,398Large
|
||||||
| RYTM |
RHYTHM PHARMACEUTICALS, INC.
|
Officer • Chief Technical Officer
10b5-1 SellΔOwn -53.4%
|
2025-10-30 | $1,123,398Large | S | Form 4 |
|
RYTM
S
RHYTHM PHARMACEUTICALS, INC.
Shulman Joseph
• Officer • Chief Technical Officer
10b5-1 SellΔOwn -24.9%
2025-10-28
$323,750
|
||||||
| RYTM |
RHYTHM PHARMACEUTICALS, INC.
|
Officer • Chief Technical Officer
10b5-1 SellΔOwn -24.9%
|
2025-10-28 | $323,750 | S | Form 4 |
|
RYTM
S
RHYTHM PHARMACEUTICALS, INC.
Shulman Joseph
• Officer • Chief Technical Officer
10b5-1 SellΔOwn -11.7%
2025-10-16
$1,617,337Largex3
|
||||||
| RYTM |
RHYTHM PHARMACEUTICALS, INC.
|
Officer • Chief Technical Officer
10b5-1 SellΔOwn -11.7%
|
2025-10-16 | $1,617,337Largex3 | S | Form 4 |